OTCMKTS:VDRM ViaDerma (VDRM) Stock Price, News & Analysis 0.0059 0.00 (-4.84%) (As of 09/6/2024 08:50 PM ET) Add Compare Share Share Today's Range0.01▼0.0150-Day Range N/A52-Week Range0.00▼0.02Volume643,300 shsAverage Volume1.42 million shsMarket CapitalizationN/AP/E Ratio0.00Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartShort InterestStock AnalysisChartShort Interest Get ViaDerma alerts: Email Address Ad Golden CrestBiden's Successor: The Radical Threat to YOUR Savings!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.>> Get Your FREE Wealth Protection Guide << About ViaDerma Stock (OTCMKTS:VDRM)ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company's lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries. It is also developing products in various fields of use, including topical antibiotics, toenail antifungal drugs, diabetic amputations, global acne, psoriasis, and eczema, as well as burns, anti-aging/wrinkle remover creams, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. The company was formerly known as Décor Products International, Inc. and changed its name to ViaDerma, Inc. in May 2014. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California.Read More VDRM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VDRM Stock News HeadlinesAugust 14, 2024 | finance.yahoo.comViaDerma Announces Shipment of 500,000 Units of its Flagship Product to NigeriaAugust 13, 2024 | globenewswire.comViaDerma Announces Shipment of 500,000 Units of its Flagship Product to NigeriaSeptember 7, 2024 | Porter & Company (Ad)The death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.August 1, 2024 | globenewswire.comViaDerma Finalizes Distribution Agreements in Dubai and Announces Six New Key HiresJune 6, 2024 | globenewswire.comViaDerma Provides Highlights of Quarterly Financial ReportMay 16, 2024 | finance.yahoo.comViaDerma, Inc. (VDRM)March 3, 2024 | morningstar.comViaDerma Inc VDRMOctober 24, 2023 | finance.yahoo.comViaDerma Update on Stability Testing, Global Sales Distribution, National Licensing, Nupelo & MoreSeptember 7, 2024 | Porter & Company (Ad)The death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.July 6, 2023 | finance.yahoo.comViaDerma Announces Updates for Vitastem Global Sales Expansion, Nupelo FDA-Registration Status & MoreApril 18, 2023 | finance.yahoo.comViaDerma, Inc. (VDRM) Stock Historical Prices & Data - Yahoo FinanceMarch 16, 2023 | finance.yahoo.comViaDerma Announces FDA Registration Application Update & Brand Name for New Hair Regrowth ProductMarch 8, 2023 | finance.yahoo.comViaDerma Announces Intent to Launch a New Minoxidil Hair Regrowth ProductMarch 2, 2023 | finance.yahoo.comViaDerma Provides an Update on Current & Future Business ActivitiesJanuary 12, 2023 | benzinga.comViaDerma Retains Digital Marketing Leader INTENT SCIENCES to Accelerate Business Growth OnlineSeptember 15, 2022 | finance.yahoo.comViaDerma Successfully Completes Quality Control Testing of its New Vitastem ProductsJune 22, 2022 | finance.yahoo.comViaDerma Announces the Implementation of Internal Quality Control Measures for its New Vitastem ProductsApril 1, 2022 | nz.finance.yahoo.comAvoteo emerges as the first crowdfunding platform without spending moneySee More Headlines Receive VDRM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ViaDerma and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:VDRM CUSIPN/A CIKN/A Webviadermalicensing.com Phone(310) 734-6111FaxN/AEmployees75Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio0.00 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Qing Hua Lin (Age 43)Chief Financial Officer and Director Comp: $4.46kMr. Baotang Zhao (Age 46)Chief Sales Officer Comp: $28.77kMr. Zhang Xie (Age 45)Corporate Secretary and Director Comp: $9.18kDr. Christopher A OtikoFounder, Chief Executive Officer and PresidentDr. Andrew Berman M.D.MPH, Medical Director and Member of Advisory BoardKey Competitors180 Life SciencesNASDAQ:ATNFW4D pharmaNASDAQ:LBPSW4Front VenturesOTCMKTS:FFNTFAbattis BioceuticalsOTCMKTS:ATTBFAeolus PharmaceuticalsOTCMKTS:AOLSView All Competitors VDRM Stock Analysis - Frequently Asked Questions How have VDRM shares performed this year? ViaDerma's stock was trading at 0.01 at the beginning of the year. Since then, VDRM shares have decreased by 44.3% and is now trading at 0.01. View the best growth stocks for 2024 here. How do I buy shares of ViaDerma? Shares of VDRM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:VDRM) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ViaDerma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ViaDerma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
